Indoco gets USFDA approval for Olanzapine tablets
Olanzapine is indicated for the treatment of schizophrenia and bipolar disorder
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Indoco Remedies
Indoco announces Q4FY20 financial results; revenues stand at Rs 263 Crores
The company recorded a net profit of Rs 5.4 crores, as against Rs 11.6 crores, same quarter last year
Indoco receives US FDA approval for Succinylcholine Chloride Injection USP
Succinylcholine Chloride Injection is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to…
India’s tryst with destiny
Sundeep V Bambolkar, Joint Managing Director, Indoco Remedies outlines several measures that the Indian government must implement…
Pharmexcil requests DGFT for guidelines on procedural formalities to export paracetamol, HCQ
India has already shipped 35.82 lakh tablets of hydroxychloroquine to the US, and 11.7 lakh paracetamol tablets to the UK
Indoco receives approval for Febuxostat Tablets from US FDA
The market size of Febuxostat Tablets in USA is over USD 500 million
Indoco receives EU GMP from UK-MHRA for its Sterile facility in Goa
This is an outcome from the last successful inspection conducted by UK MHRA from 16th to 20th September 2019
Indoco’ Q2FY20 revenues grow at 21 per cent
For the quarter, the Company posted a profit of 7.3 crores, as against loss of 7.8 crores, same quarter last year
Indoco’s Clinical Research Organisation receives zero 483s from US FDA
The company also recently successfully concluded an audit by US FDA at its sterile manufacturing facility in Goa (Plant II)
Indoco Remedies gets US FDA nod for Parkinson’s disease treatment drug
The company has received final nod for its abbreviated new drug application (ANDA) for Rasagiline tablets in the strengths of 0.5…